🇨🇦 HUMAN PAPILLOMAVIRUS, L1 PROTEIN VIRUS LIKE PARTICLES in Canada

HUMAN PAPILLOMAVIRUS, L1 PROTEIN VIRUS LIKE PARTICLES (HUMAN PAPILLOMAVIRUS, L1 PROTEIN VIRUS LIKE PARTICLES) regulatory status in Canada.

Marketing authorisation

HUMAN PAPILLOMAVIRUS, L1 PROTEIN VIRUS LIKE PARTICLES in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is HUMAN PAPILLOMAVIRUS, L1 PROTEIN VIRUS LIKE PARTICLES approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for HUMAN PAPILLOMAVIRUS, L1 PROTEIN VIRUS LIKE PARTICLES in Canada?

Marketing authorisation holder not available in our data.